Korean Journal of Parasitology 2021, 2021-06: A review that states mebendazole's systematic chemical name and dates its first human application to 1971, with the original single 100 mg dose trials against Enterobius vermicularis. It also lists the early Brazilian trial of mebendazole at 100 or 200 mg twice daily for 3-4 days.
Mebendazole, methyl 5-benzoyl-1H-benzimidazol-2-yl-carbamate, is also a broad-spectrum anthelmintic, applied first to human subjects in 1971
Section 1 (Introduction)
Korean Journal of Parasitology 2021, 2021-06: A review that states mebendazole's systematic chemical name and dates its first human application to 1971, with the original single 100 mg dose trials against Enterobius vermicularis. It also lists the early Brazilian trial of mebendazole at 100 or 200 mg twice daily for 3-4 days. Study type: narrative review (not a clinical study). Country of publication: Republic of Korea. No subjects, dose regimen or comparator of its own; it summarises trials. Funder/conflicts: review's own funding and disclosure statements read in the full text – none declared for the chemistry statement quoted. Product/manufacturer: not applicable. Supports the chemistry element of C1 (defined benzimidazole carbamate structure, i.e. a synthetic small molecule) and the 1971 first-human-use date. The review cites Chaia G, Sales da Cunha A, 'Therapeutic action of mebendazole (R 17,635) against human helminthiasis', Folha Medica 1971;63:843-852 (Portuguese-language, Brazil) – that primary paper was not located online and is recorded here only as cited by this review. Study type: review.
